Endologix LLC, a privately held, global medical device company focused on advancing innovative therapies for the interventional treatment of vascular disease, today announced the acquisition of the ...

The acquisition expands Endologix’s device options for clinical partners already utilising its Detour, Alto, and AFX2 platforms.

Cagent Vascular, Inc. announces completion of first human-use cases with the Serranator SONIC IVL System and closing of $41 ...

Endologix announced the acquisition of the Pounce thrombectomy system from Surmodics, expanding the company’s portfolio of pe ...

Publicly traded global medical device company Stryker has signed a definitive agreement to acquire fellow medical technology company Amplitude Vascular Systems, adding revascularization technology to ...

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...

BioStar Capital, a venture capital firm focused on transformative medical technologies, has announced a landmark pre-FDA exit of Amplitude Vascular Systems, Inc. (AVS), a medical technology company ...